ANTX
AN2 TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ANTX vs peer average
71/100
ANTX vs. peer average (C vs. D)
Grade spread
C 2 · D 3 · F 5
Graded peers loaded
Coverage
10 graded
91% of tracked
Peer overview
BRNS is the first available peer comparator.
Low-cap biotech comparator with sentiment driven by trial progress and access to capital, making it directionally relevant for ANTX's speculative setup.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ANTX
AN2 Therapeutics
BRNS
Peer
Grade
C
-
Momentum
14
-
Value
41
-
Sentiment
71
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Unrated
Grade position vs BRNS
ANTX / BRNS
Grade Position
Above peers
ANTX vs. peer average (C vs. D)
71/100
Momentum
14
-Value
41
-Sentiment
71
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ANTX
BRNS is the first peer returned for this comparison set.